Über

Metandienone and methyltestosterone are orally active anabolic-androgenic steroids with a 17α-methyl structure that are prohibited in sports but are frequently detected in anti-doping analysis. While the rate of aromatization is reduced relative to that for testosterone or methyltestosterone, the estrogen produced is metabolism-resistant and hence metandienone retains moderate estrogenic activity. Proposed metabolism of methyltestosterone (black, 18 ) and metandienone (red, 12 ) to… Additionally, 3α,5β-tetrahydro-epi-methyltestosterone was identified in the urines of both administrations besides the classical metabolites included in the screening procedures. 17α-hydroxymethyl-17β-methyl-18-nor-5β-androst-13-en-3α-ol and its 5α-analog, were identified following an administration of methyltestosterone.
As with other 17α-alkylated AAS, metandienone may be hepatotoxic, especially with prolonged use of high doses. As the CIBA product Dianabol, metandienone quickly became the first widely used AAS among professional and amateur athletes, and remains the most common orally active AAS for non-medical use. In case a hereditary predisposition exists, metandienone can cause a possible balding. Methandienone 10mg has a strong effect on the liver that why a long-term therapy is liver-toxic. Methandienone administration in women can cause virilization symptoms.
Also, it is used in the treatment of tuberculosis, osteomyelitis, asthma, hepatitis. Using a semi-targeted approach including the synthesis of reference compounds, two diastereomeric substances, viz. There are many known cases of doping in sports with metandienone by professional athletes. It has also been marketed under a variety of other brand names including Anabol, Averbol, Chinlipan, Danabol, Dronabol, Metanabol, Methandon, Naposim, Reforvit-B, and Vetanabol among others. Non-medical use was outlawed in the U.S. under the Anabolic Steroids Control Act of 1990.
Generic production shut down two years later, when the FDA revoked metandienone's approval entirely in 1985. Following further FDA pressure, CIBA withdrew Dianabol from the U.S. market in 1983. After CIBA's patent exclusivity period lapsed, other manufacturers began to market generic metandienone in the U.S. FDA began the DESI review process to ensure the safety and efficacy of drugs approved under the more lenient pre-1962 standards, including Dianabol.
Androgenic side effects such as oily skin, acne, seborrhea, increased facial/body hair growth, scalp hair loss, and virilization may occur. Metandienone is used for physique- and performance-enhancing purposes by competitive athletes, bodybuilders, and powerlifters. Metandienone was provided in the form of 2.5, 5 and 10 mg oral tablets. Metandienone is readily available without a prescription in certain countries such as Mexico, and is also manufactured in some Asian countries.
The elimination half-life of metandienone is about 3 to 6 hours. It has very low affinity for human serum sex hormone-binding globulin (SHBG), about 10% of that of testosterone and 2% of that of DHT. As such, it can cause side effects such as gynecomastia and fluid retention. Methandienone binds to and activates the androgen receptor (AR) in order to exert its effects. Estrogenic side effects such as gynecomastia and fluid retention can also occur.
When entering the cell nucleus, it stimulates the genetic apparatus of the cell, causing the synthesis of DNA, RNA, and structural proteins, activates the enzymes of tissue respiration chain and enhancing tissue respiration, oxidative phosphorylation, ATP synthesis and intracellular aggregation macroergic. Due to its short action time 3.2 to 4.5 hours, it candy96.fun is necessary to administrate it at least twice a day in order to maintain the necessary concentration of methandienone in the blood. Metandienonum is not indicated to be used is there is hypersensitivity to the drug, prostate cancer, breast carcinoma in women with hypercalcemia, CPI, severe atherosclerosis,breast cancer in men, hepatic and renal function, acute and chronic prostatitis, pregnancy and lactation.
During Methandienone treatment, high blood pressure can happen along with fastened heartbeats which may require the administration of antihypertensive drugs. Even a dosage of only 10 mg./day has a noticeable strain on the liver but after the administration is stopped, the liver values return to normal. Although methandienone 10mg has many potential side effects, they are rare with a dosage of up to 20 mg per day. During the treatment period this medicine cases boosted muscle mass, reduce fat deposits, improves trophic tissues, promotes calcium deposits in the bones, retain nitrogen, phosphorus, sulfur, potassium, sodium and water in the body. Synthesis route for 17β-methyl-5β-androstane-3α,17α-diol ( 11 ). Synthesis route for 17β-methyl-5β-androstane-3α,17α-diol ( …
It is currently a controlled substance in the United States and United Kingdom and remains popular among bodybuilders. Metandienone was originally developed in 1955 by CIBA and marketed in Germany and the United States.
The co-administration of an antiestrogen such as an aromatase inhibitor like anastrozole or a selective estrogen receptor modulator like tamoxifen can reduce or prevent such estrogenic side effects. Metandienone is a substrate for aromatase and can be metabolized into the estrogen methylestradiol (17α-methylestradiol). As such, 5α-reductase inhibitors like finasteride and dutasteride do not reduce the androgenic effects of metandienone. As with other 17α-alkylated steroids, methandienone poses a risk of hepatotoxicity and use over extended periods of time can result in liver damage without appropriate precautions. Side effects of metandienone include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire, estrogenic effects like fluid retention and breast enlargement, and liver damage. After the treatment with metandienone, the patients feel a noticeable loss in weight and strength, due to the water excretion from the body, as it was retained in the body during the treatment period.